Vulval or vaginal cancer
Clinical Outcomes and Quality of Life in Patients With Locally Advanced Vulvovaginal Cancers: Ambispective Registration Study.
Where to go
1 hospital in India taking patients for this trial.
Registry summary (technical)
The vaginal cancers are responsible for 2% of gynecological cancer while vulvar cancers account for 4 % of gynecological cancers. HPV 16 and 33 are most prevalent in vaginal cancers and account for more than half of cases HPV related vaginal cancer. However, adeqaute information is not there. Similarly, structured QOL data is not available for India. Therefore, in the proposed study we will like to systematically evaluate the patterns of relapse and disease outcomes in patients with vulvovaginal cancer treated with radiation (+/- chemotherapy). The therapeutic research in vulvo-vaginal cancers…
Sponsor: Tata Memorial Hospital
NCT07179757 on ClinicalTrials.gov
Last updated on the registry 4 Feb 2026 · read by us 20 Oct 2026